Cedazuridine and Decitabine

INQOVI

Nucleoside Metabolic Inhibitor

NADAC/unit N/A

No Shortage Tier 1: 17.9% PA Req: 99.4%

Cedazuridine and Decitabine interferes with DNA synthesis to slow cancer cell or viral replication.

Covered Lives

Generic Manufacturers

TAIHO ONCOLOGY INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Cedazuridine and Decitabine drfinder.aiFind doctors who prescribe Cedazuridine and Decitabine rxnews.aiLatest news about Cedazuridine and Decitabine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.